EPISODE · Jun 24, 2026 · 6 MIN
An extraordinary new obesity drug is still awaiting FDA approval. Why is one man allowed access?
from Here & Now · host WBUR & NPR
Drugmaker Eli Lilly and the U.S. Food and Drug Administration have granted access to retatrutide to one man, through the FDA’s so-called “compassionate use” program.
Embed this episode
NOW PLAYING
An extraordinary new obesity drug is still awaiting FDA approval. Why is one man allowed access?
0:00
6:05
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Here & Now?
This episode is 6 minutes long.
When was this Here & Now episode published?
This episode was published on June 24, 2026.
Can I download this Here & Now episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!